Short Interest in BIO-key International, Inc. (NASDAQ:BKYI) Declines By 69.7%

BIO-key International, Inc. (NASDAQ:BKYIGet Free Report) was the recipient of a large decrease in short interest in October. As of October 15th, there was short interest totalling 12,800 shares, a decrease of 69.7% from the September 30th total of 42,300 shares. Based on an average daily volume of 2,920,000 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.5% of the company’s shares are sold short.

BIO-key International Trading Down 4.2 %

BKYI opened at $0.69 on Friday. BIO-key International has a 1 year low of $0.52 and a 1 year high of $5.58. The firm has a 50 day moving average price of $1.08 and a 200 day moving average price of $1.45. The company has a debt-to-equity ratio of 0.28, a current ratio of 0.54 and a quick ratio of 0.46.

BIO-key International (NASDAQ:BKYIGet Free Report) last released its quarterly earnings results on Wednesday, August 14th. The technology company reported ($1.00) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.54) by ($0.46). The company had revenue of $1.14 million during the quarter. BIO-key International had a negative return on equity of 673.82% and a negative net margin of 93.18%.

About BIO-key International

(Get Free Report)

BIO-key International, Inc develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform.

Featured Stories

Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.